CEO Jeff Kraws selected to moderate a Special Session "Fund Managers Unplugged" at the 6th Annual OneMedForum Conference in San Francisco on Wednesday, January 9, 2013.
Crystal Research Associates, LLC announces that its Chief Executive Officer and Co-founder, Mr. Jeffrey J. Kraws, will be moderating a Special Session at the 6th Annual OneMedForum conference in San Francisco on Wednesday, January 9, 2013. The panel, “Special Session: Fund Managers Unplugged,” is composed of veteran healthcare fund managers who have shown exceptional long-term success investing in emerging growth companies in healthcare and life sciences. These individuals are experienced investors in both good and bad markets, and they will be discussing their outlooks for 2013 and beyond—particularly in terms of sharing their unique insights as to where the areas of greatest opportunity may lie in coming years.
Special Session: Fund Managers Unplugged will be held on Wednesday, January 9, 2013, from 4:00PM-4:55PM at the Sir Francis Drake Hotel in San Francisco.
Mr. Kraws, who is well known for his years of work on Wall Street and for providing consistent award-winning analyses, is serving as panelist and moderator for Fund Managers Unplugged. He has been ranked among the top analysts in the world for pharmaceutical stock performance for almost two decades, ranked as the Number One Stock Picker in the world for pharmaceuticals by Starmine and for estimates from Zacks, and 5-Star ranked for top biotechnology stock performance by Starmine.
Additional panelists include Mr. Dennis J. Purcell, Senior Managing Partner at Aisling Capital with approximately $1.7 billion in assets under management; Dr. J. Misha Petkevich, Co-founder of BladeRock Capital and former Chairman and CEO of The Petkevich Group, LLC; and Mr. William S. Slattery, Partner at Deerfield Management Company, L.P. where he focuses on biotechnology investments.
Detailed biographies for each panelist can be accessed here.
Some of the topics to be addressed in this panel include the following:
■ Does Obamacare matter? What does the expanding role of government mean for investment strategy?
■ How does the empowered consumer and changing dynamics of health delivery change investment opportunity?
■ What are the most long-term and promising fundamental investment themes?